Omaha, Neb., December 17, 2019 — Meridian Clinical Research, a leading investigative research network, has donated more than $290,000 to people in need, fundraisers, and charitable organizations in 2019. The amount was accumulated through a novel employee incentive program that intertwines annual bonus and charitable giving budgets.
“Our communities and our patients are at the forefront of everything we do,” said Nicole Osborn, Meridian founder and CEO. “This year we launched the All In: Strength in Numbers program to help more people beyond the clinic. We set what we thought was an ambitious goal of $209,700. The team reached more than $290,000.”
A unique aspect of Meridian’s charitable program is Good Deeds Day, a tradition of spontaneous giving that began more than a decade ago. For Good Deeds Day, employees at each Meridian site are given a cash stipend and a simple instruction: Go into your community and make a difference. Meridian employees decide on the best way to support local charities or perform acts of kindness.
“I’d encourage companies to consider a hybrid employee performance and charitable giving model like this,” said Osborn. “It empowers employees at all levels to become a stronger part of Meridian’s culture while letting them decide how to invest in their communities.”
In addition to celebrating Good Deeds Day at 18 sites nationwide, Meridian provided the following:
- A donation to St. Augustine School in Haiti, which was used to rebuild eight classrooms.
- The creation of scholarships for graduating seniors pursuing a career in science or health care.
- Support for dozens of organizations and people in need chosen by Meridian employees throughout 2019.
To learn more about Meridian, and to view current study and career opportunities at its locations, visit mcrmed.com.
—
ABOUT MERIDIAN CLINICAL RESEARCH
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new pharmaceutical drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at a dedicated research center in Omaha, NE, and conducts Phase 1-4 studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. For more information, visit www.mcrmed.com.
—
MEDIA INQUIRIES
Sally Kahre
Meridian Clinical Research
(402) 933-6500
skahre@mcrmed.com